CellCentric, a clinical-stage biotechnology company, has completed an oversubscribed US$220m Series D financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management & Research Company, Sofinnova Partners and…
UK: CellCentric raises US$220m in oversubscribed Series D financing
…
…






